GSK hands back failed muscular dystrophy drug to Prosensa

[riky]

GSK hands back failed muscular dystrophy drug to Prosensa

<p><a href="http://news.yahoo.com/gsk-hands-back-failed-muscular-dystrophy-drug-prosensa-133230698--finance.html"><img src="http://l2.yimg.com/bt/api/res/1.2/Mq3bu9pDZQGFvQhJeCOMEg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-01-13T133230Z_1_CBREA0C11M900_RTROPTP_2_GSK-CHINA.JPG" width="130" height="86" alt="The signage for the GlaxoSmithKline building is pictured in London" align="left" title="The signage for the GlaxoSmithKline building is pictured in London" border="0" /></a>By Ben Hirschler LONDON (Reuters) - GlaxoSmithKline has handed back rights to an experimental drug for Duchenne muscular dystrophy to U.S.-listed Dutch biotech firm Prosensa after it failed last year in a critical clinical trial. Both companies said on Monday that Prosensa would now have full and unencumbered rights to drisapersen, as well as other compounds at an earlier stage of development.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login